Centessa Pharmaceuticals plc CEO Saurabh Saha's 2023 pay falls 72% to $2.7M

Centessa Pharmaceuticals plc reports 2023 executive compensation

By ExecPay News

Published: May 9, 2024

Centessa Pharmaceuticals plc reported fiscal year 2023 executive compensation information on May 9, 2024.
In 2023, four executives at Centessa Pharmaceuticals plc received on average a compensation package of $1.7M, a 60% decrease compared to previous year.
Average pay of disclosed executives at Centessa Pharmaceuticals plc
Saurabh Saha, Chief Executive Officer, received $2.7M in total, which decreased by 72% compared to 2022. 31% of Saha's compensation, or $850K, was in option awards. Saha also received $377K in bonus, $652K in salary, $814K in stock awards, as well as $13K in other compensation.
Antoine Yver, Chairman, received a compensation package of $1.4M, which decreased by 45% compared to previous year. 39% of the compensation package, or $538K, was in salary.
David Grainger, Former Chief Innovation Officer, earned $1.4M in 2023, a 44% decrease compared to previous year.
David Chao, Chief Administrative Officer, received $1.3M in 2023, which decreases by 60% compared to 2022.

Related executives

Saurabh Saha

Centessa Pharmaceuticals plc

Chief Executive Officer

David Grainger

Centessa Pharmaceuticals plc

Former Chief Innovation Officer

David Chao

Centessa Pharmaceuticals plc

Chief Administrative Officer

Antoine Yver

Centessa Pharmaceuticals plc

Chairman

You may also like

Source: SEC filing on May 9, 2024.